Intellia Therapeutics, Inc. (NASDAQ: NTLA) (before the market open)
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) (before the market open)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) (before the market open)
Insmed Incorporated (NASDAQ: INSM) (before the market open)
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) (before the market open)
Endo International plc (NASDAQ: ENDP) (before the market open)
Bio-Techne Corporation (NASDAQ: TECH) (before the market open)
Harvard Bioscience, Inc. (NASDAQ: HBIO) (before the market open)
Athenex, Inc. (NASDAQ: ATNX) (before the market open)
Zoetis Inc. (NYSE: ZTS) (before the market open)
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (before the market open)
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) (before the market open)
Endo s Qwo (collagenase clostridium histolyticum-aaes) Data to Be Presented at The Aesthetic Meeting 2021
DUBLIN, April 29, 2021 /PRNewswire/ Endo International plc (NASDAQ: ENDP) announced today that data relevant to the use of Endo Aesthetics Qwo (collagenase clostridium histolyticum-aaes), which received FDA approval in July 2020 for the treatment of moderate to severe cellulite in the buttocks of adult women, will be presented during The Aesthetic Meeting 2021.
This data will be highlighted in two oral presentations during the virtual and in-person meeting taking place in Miami, FL April 29-May 3, 2021. Reduction in Dimple Volume in Women With Buttock Cellulite Treated With Collagenase Clostridium Histolyticum-aaes; Lawrence Bass, M.D., medical director and founder, Bass Plastic Surgery, PLLC, and QWO clinical trial investigator; Sunday, May 2
Share this article
Share this article
DUBLIN, April 29, 2021 /PRNewswire/ Endo International plc (NASDAQ: ENDP) announced today that data relevant to the use of Endo Aesthetics Qwo
® (collagenase clostridium histolyticum-aaes), which received FDA approval in July 2020 for the treatment of moderate to severe cellulite in the buttocks of adult women, will be presented during The Aesthetic Meeting 2021.
This data will be highlighted in two oral presentations during the virtual and in-person meeting taking place in Miami, FL April 29–May 3, 2021. Reduction in Dimple Volume in Women With Buttock Cellulite Treated With Collagenase Clostridium Histolyticum-aaes; Lawrence Bass, M.D., medical director and founder, Bass Plastic Surgery, PLLC, and QWO clinical trial investigator; Sunday, May 2
Endo s Qwo® (collagenase clostridium histolyticum-aaes) Data to Be Presented at The Aesthetic Meeting 2021 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.